Lactic acidosis as side-effect of metformin;Melkesyreacidose som bivirkning av metformin

Tidsskrift for den Norske Laegeforening

Volumn 123, Issue 18, 2003, Pages 2583-2584

  Hanssen, Kristian F ^a  

^a AKER UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

METFORMIN; ANTIDIABETIC AGENT;

DIABETES CONTROL; GLUCOSE BLOOD LEVEL; HUMAN; LACTIC ACIDOSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; SHORT SURVEY; SIDE EFFECT; ARTICLE; CHEMICALLY INDUCED DISORDER; DRUG CONTRAINDICATION;

ACIDOSIS, LACTIC; HUMANS; HYPOGLYCEMIC AGENTS; METFORMIN;

EID: 1342331595     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (9)

1. UKPDS Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study Group. Lancet. 1998; 352: 854-65.
2. Ronning M, red. Legemiddelforbruket i Norge 1998-2002. Oslo: Nasjonalt folkehelseinstitutt, 2003.
3. Witters LA. The blooming of the French lilac. J Clin Invest 2001; 1105-7.
4. Brown JB, Pedula K, Barzilay J, Herson MK, Latare P. Lactic acidosis rates in type 2 diabetes. Diabetes Care 1998; 21: 1659-63.
5. Chan NN, Brain HPS, Feher MD. Metformin-associated lactic acidosis: a rare or a very rare clinical entity? Diab Med 1999; 16, 273-81.
6. Statens legemiddelverk. www.legemiddelverket.no (25.3.2003).
7. Klow NE, Draganov B, Os I. Metformin og røntgenkontrastmidler - økt risiko for melkesyreacidose? Tidsskr Nor Lægeforen 2001; 121: 1829.
8. Rachmani R, Slavachevski I, Levi Z, Zadok B, Kedar Y, Ravid M. Metformin in patients with type 2 diabetes mellitus: reconsideration of traditional contraindications. Eur J Intern Med 2002; 13: 428-33.
9. Jones GC, Macklin JP, Alexander WD. Contraindications to the use of metformin. BMJ 2003; 32: 4-5.